2018
DOI: 10.4103/jcecho.jcecho_61_17
|View full text |Cite
|
Sign up to set email alerts
|

An Unusual Left Atrial Mass in a Woman with Active Breast Cancer and Recent Cardiothoracic Surgery

Abstract: Atrial masses are rare and more often localized in the right atrium. They are usually detected incidentally, and the leading causes are tumors, thrombi, or infective vegetations. However, normal structures and artifacts (“pseudomasses”) should also be considered in differential diagnosis, especially after cardiac and/or aortic surgery. We present a case of an unusual left atrial image observed on transthoracic echocardiography in an 83-year-old woman after an intervention of open-chest ascending aorta replacem… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2019
2019
2020
2020

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 5 publications
0
2
0
Order By: Relevance
“…A mass in the left atrium can be challenging to diagnose. The leading differential diagnoses include thrombus, vegetation and tumor, which may be primary (benign or malignant) or metastatic [1]. We would like to present a case of mass in the left atrium found in a 61-year-old woman which turned out to be metastatic invasion to the heart from the lesions in the lungs.…”
Section: Introductionmentioning
confidence: 99%
“…A mass in the left atrium can be challenging to diagnose. The leading differential diagnoses include thrombus, vegetation and tumor, which may be primary (benign or malignant) or metastatic [1]. We would like to present a case of mass in the left atrium found in a 61-year-old woman which turned out to be metastatic invasion to the heart from the lesions in the lungs.…”
Section: Introductionmentioning
confidence: 99%
“…Cancer and chemotherapy are known to be risk factors for developing coagulative disorders, thrombosis, adverse cardiovascular events, and cardiotoxicity. [12] Combined modality gemcitabine–cisplatin chemotherapy is often administered to treat a few solid tumors, including non-small cell lung cancer, esophageal, gastric, testicular, and urothelial neoplasms. [3]…”
Section: Introductionmentioning
confidence: 99%